99 related articles for article (PubMed ID: 23086767)
1. Molecular diagnostics of melanoma fine-needle aspirates: a cytology-histology correlation study.
Bernacki KD; Betz BL; Weigelin HC; Lao CD; Redman BG; Knoepp SM; Roh MH
Am J Clin Pathol; 2012 Nov; 138(5):670-7. PubMed ID: 23086767
[TBL] [Abstract][Full Text] [Related]
2. Application of immunocytochemistry and BRAF mutational analysis to direct smears of metastatic melanoma.
Hookim K; Roh MH; Willman J; Placido J; Weigelin HC; Fields KL; Pang J; Betz BL; Knoepp SM
Cancer Cytopathol; 2012 Feb; 120(1):52-61. PubMed ID: 21793228
[TBL] [Abstract][Full Text] [Related]
3. Detection of BRAF mutation in metastatic melanoma utilizing cell-transferred cytological smears.
Chen S; Randolph M; Cramer HM; Watkins T; McCullough H; Post KM; Sen JD; Cheng L; Wu HH
Acta Cytol; 2014; 58(5):478-82. PubMed ID: 25359156
[TBL] [Abstract][Full Text] [Related]
4. Assessment of V600E mutation of BRAF gene and rate of cell proliferation using fine-needle aspirates from metastatic melanomas.
Sviatoha V; Tani E; Ghaderi M; Kleina R; Skoog L
Anticancer Res; 2010 Sep; 30(9):3267-72. PubMed ID: 20944096
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma.
Long GV; Wilmott JS; Capper D; Preusser M; Zhang YE; Thompson JF; Kefford RF; von Deimling A; Scolyer RA
Am J Surg Pathol; 2013 Jan; 37(1):61-5. PubMed ID: 23026937
[TBL] [Abstract][Full Text] [Related]
6. Preparation of thyroid FNA material for routine cytology and BRAF testing: a validation study.
Troncone G; Cozzolino I; Fedele M; Malapelle U; Palombini L
Diagn Cytopathol; 2010 Mar; 38(3):172-6. PubMed ID: 19693938
[TBL] [Abstract][Full Text] [Related]
7. BRAF(V600E) mutation analysis of liquid-based preparation-processed fine needle aspiration sample improves the diagnostic rate of papillary thyroid carcinoma.
Chang H; Lee H; Yoon SO; Kim H; Kim A; Kim BH
Hum Pathol; 2012 Jan; 43(1):89-95. PubMed ID: 21774961
[TBL] [Abstract][Full Text] [Related]
8. Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis.
Willmore-Payne C; Holden JA; Tripp S; Layfield LJ
Hum Pathol; 2005 May; 36(5):486-93. PubMed ID: 15948115
[TBL] [Abstract][Full Text] [Related]
9. BRAF mutation analysis in fine needle aspiration (FNA) cytology of the thyroid.
Jin L; Sebo TJ; Nakamura N; Qian X; Oliveira A; Majerus JA; Johnson MR; Lloyd RV
Diagn Mol Pathol; 2006 Sep; 15(3):136-43. PubMed ID: 16932068
[TBL] [Abstract][Full Text] [Related]
10. [BRAF V600E mutation in papillary thyroid carcinoma: prevalence and detection in fine needle aspiration specimens].
Dujardin F; Pagès JC; Collin C; de Calan L; Lecomte P; Guyétant S
Ann Pathol; 2010 Aug; 30(4):252-62. PubMed ID: 20837233
[TBL] [Abstract][Full Text] [Related]
11. Incidence of BRAF p.Val600Glu and p.Val600Lys mutations in a consecutive series of 183 metastatic melanoma patients from a high incidence region.
Amanuel B; Grieu F; Kular J; Millward M; Iacopetta B
Pathology; 2012 Jun; 44(4):357-9. PubMed ID: 22614711
[TBL] [Abstract][Full Text] [Related]
12. BRAF V600 Mutational Status in Melanoma Correlates with Cytologic Features in Fine-Needle Aspirate Specimens.
Lee PJ; Dennis K; Madan R; Fan F
Acta Cytol; 2019; 63(1):10-16. PubMed ID: 30396186
[TBL] [Abstract][Full Text] [Related]
13. Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma.
Menzies AM; Haydu LE; Visintin L; Carlino MS; Howle JR; Thompson JF; Kefford RF; Scolyer RA; Long GV
Clin Cancer Res; 2012 Jun; 18(12):3242-9. PubMed ID: 22535154
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.
Long GV; Menzies AM; Nagrial AM; Haydu LE; Hamilton AL; Mann GJ; Hughes TM; Thompson JF; Scolyer RA; Kefford RF
J Clin Oncol; 2011 Apr; 29(10):1239-46. PubMed ID: 21343559
[TBL] [Abstract][Full Text] [Related]
15. Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules.
Kim SK; Kim DL; Han HS; Kim WS; Kim SJ; Moon WJ; Oh SY; Hwang TS
Diagn Mol Pathol; 2008 Jun; 17(2):118-25. PubMed ID: 18382358
[TBL] [Abstract][Full Text] [Related]
16. BRAF mutation screening in melanoma: is sentinel lymph node reliable?
Nardin C; Puzenat E; Prétet JL; Algros MP; Doussot A; Puyraveau M; Mougin C; Aubin F
Melanoma Res; 2015 Aug; 25(4):328-34. PubMed ID: 26020488
[TBL] [Abstract][Full Text] [Related]
17. Detection of BRAFV600E mutation on papillary thyroid carcinoma and metastatic malignant melanoma by fine-needle aspiration cytology: how genetic testing may drive toward personalized medicine.
Rocca BJ; Ambrosio MR; Ginori A; Disanto A
Diagn Cytopathol; 2014 Oct; 42(10):877-9. PubMed ID: 24574369
[TBL] [Abstract][Full Text] [Related]
18. Detection of BRAF p.V600E Mutations in Melanoma by Immunohistochemistry Has a Good Interobserver Reproducibility.
Marin C; Beauchet A; Capper D; Zimmermann U; Julié C; Ilie M; Saiag P; von Deimling A; Hofman P; Emile JF
Arch Pathol Lab Med; 2014 Jan; 138(1):71-5. PubMed ID: 23651150
[TBL] [Abstract][Full Text] [Related]
19. Benign nodal nevi frequently harbor the activating V600E BRAF mutation.
Taube JM; Begum S; Shi C; Eshleman JR; Westra WH
Am J Surg Pathol; 2009 Apr; 33(4):568-71. PubMed ID: 19033861
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic dilemmas of hyalinizing trabecular tumours on fine needle aspiration cytology: a study of seven cases with BRAF mutation analysis.
Kim T; Oh YL; Kim KM; Shin JH
Cytopathology; 2011 Dec; 22(6):407-13. PubMed ID: 21733000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]